Older adults with acute myeloid leukemia

This publication has 74 references indexed in Scilit:

• Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
  New England Journal of Medicine, 2002
• Efficacy of granulocyte colony‐stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study
  British Journal of Haematology, 2002
• Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
  New England Journal of Medicine, 2001
• Acute Myeloid Leukemia
  Hematology-American Society Hematology Education Program, 2001
• De Novo and Secondary Acute Myeloid Leukemia in Patients over the Age of 65: A Review of Fifty-Six Successive and Unselected Cases from a General Hospital
  Leukemia & Lymphoma, 1999
• A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia
  British Journal of Haematology, 1998
• Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course
  British Journal of Haematology, 1996
• AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial
  British Journal of Haematology, 1989
• Myelodysplastic syndromes: Analysis of 131 cases according to the FAB classification
  European Journal of Haematology, 1987
• PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIAL
  The Lancet, 1986